Navigation Links
IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/4/2010

s of creating a very efficient and scalable business."

"We have recorded our fourth consecutive quarter of profitability. Our operating income for the year was $2.5 million an all time high for the Company, compared to 2008 where the Company had an operating loss of $2.2 million (excluding impairment charges). This is an outstanding achievement especially given the current economy. We are particularly pleased with the improvement in gross margins and the fact that we have sustained these improvements throughout the year, and we continue to control our operating expenses. In summary, we met our 2009 objectives of being cash flow positive, driving to profitability and positioning ourselves for future growth."

"During the fourth quarter we saw a very steady order rate for Ophthalmology Equipment which adds to our confidence for 2010. We see broadening interest in our recently introduced IQ 577 yellow laser. These facts, together with other initiatives we are undertaking, provide new growth opportunities for 2010. Looking forward, based on our performance for 2009, our financial model has our gross margins in the range of 45% to 50% with operating expenses between 40% and 42% for the year; and we are making progress towards our long term goals of 55% gross margins and 40% operating expenses."


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
2. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
3. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
4. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
5. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015 Following ... of their transactions, Array BioPharma Inc. (NASDAQ:  ARRY) ... and encorafenib definitive agreements with Novartis.  Along with ... an upfront payment of $85 million from Novartis. ... noted, "With the close of the Novartis-GSK transaction, ...
(Date:3/2/2015)... 2, 2015  The International Myeloma Foundation (IMF), ... myeloma patients while working toward prevention and a ... March to be Myeloma Awareness Month (#MAM). ... Awareness Month in 2009. Throughout the month, the ... community events, social media campaigns, story sharing, and ...
(Date:3/2/2015)... -- Cardinal Health today announced plans to acquire Johnson ... cardiology and endovascular devices, for $1.944 billion in cash, ... of tax benefits. The acquisition is expected to be ... senior unsecured notes and the remainder with existing cash. ... the United States and key non-U.S. countries ...
Breaking Medicine Technology:Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5International Myeloma Foundation Declares March "Myeloma Awareness Month" 2International Myeloma Foundation Declares March "Myeloma Awareness Month" 3Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 2Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 3Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 4Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 5Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 6Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash 7
... Dec. 8, 2011  RainTree Oncology Services (RainTree Oncology), ... and management services, today announced it has signed ... the nation,s largest privately-owned specialty pharmacy providing medication ... the Company to provide community oncology practices with ...
... 2011   Leatt Corporation (OTC: LEAT.PK), a global ... brace system designed to help prevent potentially devastating injuries ... today that the 2011 Annual Meeting (Meeting) of its ... Thursday, December 22, 2011.  Stockholders of record as of ...
Cached Medicine Technology:RainTree Oncology Services Announces Service Agreement With Diplomat Specialty Pharmacy 2RainTree Oncology Services Announces Service Agreement With Diplomat Specialty Pharmacy 3Leatt Corporation Announces 2011 Annual Shareholders' Meeting 2
(Date:3/2/2015)... 2015 ZoomCare announced today the ... healthcare. Zoom will expand its Portland on-demand neighborhood ... advanced care studios delivering urgent care, primary care, ... care and outpatient surgery. With its new neighborhood ... all healthcare needs outside of hospitalization. , “2015 ...
(Date:3/2/2015)... York (PRWEB) March 02, 2015 ... at Recovery Unplugged™—will be delivering a plenary address ... Perspective on the Art of Healing and Recovery ... (NCAD) and Behavioral Healthcare Executive Summit (BHES).     , ... Mr. Supa’s songs have been recorded by some ...
(Date:3/2/2015)... March 02, 2015 This year, the National ... and will provide opportunities for people across the country to ... help people with MS live their best lives. MS Awareness ... to inspire others to join the Society’s vision of a ... unpredictable, often disabling disease of the central nervous system, interrupts ...
(Date:3/2/2015)... Regulatory Compliance Associates® Inc. (RCA), ... and technical consulting, announces Mr. Seyed Khorashahi has ... , Before joining RCA, Mr. Khorashahi had over ... all aspects of developing safety-critical medical devices. ... Regulatory Compliance Associates Inc., Baxter Healthcare, and Beckman ...
(Date:3/2/2015)... Many mainstream media outlets have run stories ... how much of that news reporting is true? Many ... measles, but whose youngsters later developed autism, will assemble ... comprised of professionals, clinicians, researchers, therapists, advocates, and others. ... questions about the body and childhood health will have ...
Breaking Medicine News(10 mins):Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Growing List of Professionals Gather for World’s Most Comprehensive Autism Conference in Chicago, May 2015 2
... 18, 2008 TAP Pharmaceutical Products Inc. today reported ... new drug TAK-390MR, the first proton pump inhibitor (PPI) ... patients with erosive esophagitis (EE) and in maintenance of ... Disease Week (DDW) annual meeting in San Diego. , ...
... the 2000 census, Americans office workers spend an average ... work stations. Many recent studies on job satisfaction have ... environments, often under artificial light in windowless offices, report ... can employers make office environments more conducive to productivity ...
... 19 Volcano Corporation,(Nasdaq: VOLC ), a ... Optical Coherence Tomography (OCT) products designed,to enhance the ... said today that it will be participating in ... May 20., The presentation by Scott Huennekens, ...
... and progression of prostate cancer have eluded scientists ... have identified a specific gene expression profile of ... future treatments. The findings, published in BioMed Centrals ... that are differentially expressed in certain prostate cancer ...
... CHICAGO, May 19 SmithAmundsen LLC is pleased,to announce ... Chicago office,has been elected partner, effective May 17, 2008., ... Health Care practice group,focusing her work on health care ... Health Care Agencies, involving,the defense of both nursing and ...
... 19 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... rejoined the company in a part-time position ... owned subsidiary of Alexza. Mr.,Williams will have ... Singapore and establishing potential joint ventures in,Singapore. ...
Cached Medicine News:Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 2Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 3Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 4Health News:Greener offices make happier employees 2Health News:Volcano Corporation Presentation at JMP Conference to be Webcast 2Health News:Mapping of prostate cancer genes opens the door to new treatments 2Health News:SmithAmundsen Elects New Partner, Linda F. Newman 2Health News:Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd. 2Health News:Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd. 3
Inquire...
... - Anatomically designed to enhance the chin contour, ... mandible with a high-profile central chin projection. ... entire mandible, this implant provides a high central ... arms. Cleft Chin Implants - Designed with ...
... IEC CL40 and FL40 Centrifuge Series ... and versatility to increase your productivity ... broad array of rotors and accessories ... microplate applications, the IEC CL40 and ...
... Series offers unsurpassed versatility and exceptional ... liter benchtop centrifuge. With its broad ... high-speed centrifugation capabilities, the IEC CL31 ... to meet a variety of sample ...
Medicine Products: